- Separation of deferiprone and its iron chelate using capillary electrophoresis2008 | Faculty of Science
- Deferiprone does not protect against chronic anthracycline cardiotoxicity in vivo2008 | Central Library of Charles University
- Deferiprone does not protect against chronic anthracycline cardiotoxicity in vivo +12008 | Faculty of Medicine in Hradec Králové
- Utilization of CE and MEKC for separation of deferiprone and its iron chelate2007 | Faculty of Science
- Trial of Deferiprone in Parkinson's Disease2022 | First Faculty of Medicine
- A comparative study of deferasirox and deferiprone in the treatment of iron overload in patients with myelodysplastic syndromes2013 | Publication without faculty affiliation
- The effect of the oral iron chelator deferiprone on the liver damage induced by tamoxifen in female rats2011 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- The effect of iron(III) on the activity of selenoenzymes and oxidative damage in the liver of rats. Interaction with natural antioxidants and deferiprone2010 | Faculty of Medicine in Pilsen
- Efficacy and safety of administration of oral iron chelator deferiprone in patients with early myelodysplastic syndrome2011 | First Faculty of Medicine
- Efficacy and safety of administration of oral iron chelator deferiprone in patients with early myelodysplastic syndrome2011 | Publication without faculty affiliation
- Deferiprone does not protect against chronic anthracycline cardiotoxicity in vivo2008 | Faculty of Pharmacy in Hradec Králové
- Effect of deferiprone on lead-induced oxidative damage and trace element level in rats2001 | Faculty of Medicine in Pilsen
- Can deferiprone (a novel intracellular iron chelator) afford significant protection against chronic anthracycline cardiotoxicity in vivo?Publication without faculty affiliation
- Effect of deferiprone on tamoxifen-induced liver injury in rats2009 | Faculty of Medicine in Pilsen
- Tamoxifen hepatotoxicity - interaction with resveratrol and deferiprone in rats2009 | Faculty of Medicine in Pilsen
- Safety and efficacy of deferiprone for pantothenate kinase-associated neurodegeneration : a randomised, double-blind, controlled trial and an open-label extension study2019 | First Faculty of Medicine
- The influence of deferiprone (L 1) and deferoxamine on the level of essential elements in mice1999 | Faculty of Medicine in Pilsen, Central Library of Charles University
- Oxidative damage caused by iron loading. The influence of deferoxamine and deferiprone2001 | Faculty of Medicine in Pilsen, Central Library of Charles University
- The influence of deferiprone (L1) and deferoxamine on iron and essential element tissue level and parameters of oxidative status in dietary iron-loaded mice2002 | Faculty of Medicine in Pilsen, Central Library of Charles University
- Effect of deferiprone on lead-induced oxidative damage and trace element level in ratsPublication without faculty affiliation
- Effect of deferiprone on the changes in lead-induced oxidative damage and trace element level in rats2001 | Faculty of Medicine in Pilsen
- Toxicological and pharmacological effects of l-deferiprone. Prospects for improving its efficacy and safety by new therapeutic interventions1997 | Faculty of Medicine in Pilsen
- The effect of the oral iron chelator deferiprone on the liver damage induced by tamoxifen in female rats2009 | Faculty of Medicine in Pilsen
- The effect of iron (FE III) on the activity of selenoenzymes and oxidative damage in rats - interaction with natural antioxidants and deferiprone2008 | Faculty of Medicine in Pilsen
- Comparison of various iron chelators used in clinical practice as protecting agents against catecholamine-induced oxidative injury and cardiotoxicity2011 | Faculty of Pharmacy in Hradec Králové
- Pharmacological cardioprotection with iron chelators and anthracycline cardiotoxicity +1Publication without faculty affiliation
- Neurodegeneration with brain iron accumulation2012 | First Faculty of Medicine
- Erythropoietin administration may potentiate mobilization of storage iron in patients on oral iron chelation therapy2006 | First Faculty of Medicine